Vitamin D and Tuberculosis

Current Respiratory Medicine Reviews

Volumn 7, Issue 6, 2011, Pages 435-439

  Mitchell, Kirsten ^a   Griffiths, Christopher J ^a   Martineau, Adrian R ^a,b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

Clinical trials; Immunomodulation; Tuberculosis; Vitamin d

Indexed keywords

25 HYDROXYVITAMIN D; BETA DEFENSIN 2; CALCITRIOL; CATHELICIDIN; COLECALCIFEROL; ERGOCALCIFEROL; VITAMIN D; VITAMIN D BINDING PROTEIN; VITAMIN D RECEPTOR;

ANTIBACTERIAL ACTIVITY; BACTERIAL GROWTH; DNA POLYMORPHISM; EDITORIAL; GROWTH REGULATION; HUMAN; IMMUNOMODULATION; INFECTION SENSITIVITY; MONONUCLEAR PHAGOCYTE; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; PHOTOTHERAPY; PRIORITY JOURNAL; SINGLE DRUG DOSE; SPUTUM CULTURE; TUBERCULOSIS; VITAMIN D DEFICIENCY; VITAMIN METABOLISM; VITAMIN SUPPLEMENTATION; WORLD HEALTH ORGANIZATION;

EID: 81155123870     PISSN: 1573398X     EISSN: 18756387     Source Type: Journal    
DOI: 10.2174/157339811798072685     Document Type: Editorial

References (64)

1. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999; 282(7): 677-86.
2. Horsburgh CR, Jr. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 2004; 350(20): 2060-2067.
3. Wood R, Maartens G, Lombard CJ. Risk factors for developing tuberculosis in HIV-1-infected adults from communities with a low or very high incidence of tuberculosis. J Acquir Immune Defic Syndr 2000; 23(1): 75-80.
4. WHO. Global tuberculosis control: a short update to the 2009 report. Geneva; 2009.
5. Raab W. Vitamin D - its bactericidal action. Chest 1946; 12: 409-415.
6. Rook GA, Steele J, Fraher L, et al. Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 1986; 57(1): 159-163.
7. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311(5768): 1770-1773.
8. Krutzik SR, Hewison M, Liu PT, et al. IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J Immunol 2008; 181(10): 7115-7120.
9. Vieth R, McCarten K, Norwich KH. Role of 25-hydroxyvitamin D3 dose in determining rat 1,25-dihydroxyvitamin D3 production. Am J Physiol 1990; 258(5 Pt 1): E780-E789.
10. Norman AW, Mizwicki MT, Norman DP. Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nat Rev Drug Discov 2004; 3(1): 27-41.
11. Martineau AR, Wilkinson KA, Newton SM, et al. IFN-{gamma}- and TNF-Independent Vitamin D-Inducible Human Suppression of Mycobacteria: The Role of Cathelicidin LL-37. J Immunol 2007; 178(11): 7190-7198.
12. Rockett KA, Brookes R, Udalova I, Vidal V, Hill AV, Kwiatkowski D. 1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect Immun 1998; 66(11): 5314-5321.
13. Sly LM, Lopez M, Nauseef WM, Reiner NE. 1alpha,25- Dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase. J Biol Chem 2001; 276(38): 35482-35493.
14. Anand PK, Kaul D. Vitamin D3-dependent pathway regulates TACO gene transcription. Biochem Biophys Res Commun 2003; 310(3): 876-877.
15. Hmama Z, Sendide K, Talal A, Garcia R, Dobos K, Reiner NE. Quantitative analysis of phagolysosome fusion in intact cells: inhibition by mycobacterial lipoarabinomannan and rescue by an 1alpha,25-dihydroxyvitamin D3-phosphoinositide 3-kinase pathway. J Cell Sci 2004; 117(10): 2131-2140.
16. Coussens A, Timms PM, Boucher BJ, et al. 1alpha,25- dihydroxyvitamin D inhibits matrix metalloproteinases induced by Mycobacterium tuberculosis infection. Immunology 2009; 127(4): 539-548.
17. Liu PT, Schenk M, Walker VP, et al. Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS One 2009; 4(6): e5810.
18. Martineau AR, Newton SM, Wilkinson KA, et al. Neutrophilmediated innate immune resistance to mycobacteria. J Clin Invest 2007; 117(7): 1988-1994.
19. Yuk JM, Shin DM, Lee HM, et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell host & microbe 2009; 6(3): 231-243.
20. Liu PT, Stenger S, Tang DH, Modlin RL. Cutting edge: vitamin Dmediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol 2007; 179(4): 2060-2063.
21. Chapman HT. On the use of cod-liver oil in diseases of the bones and joints, in consumption and in other maladies attended by great emaciation. Phamaceutical Transactions 1849: 1-16.
22. Karyadi E, West CE, Schultink W, et al. A double-blind, placebocontrolled study of vitamin A and zinc supplementation in persons with tuberculosis in Indonesia: effects on clinical response and nutritional status. Am J Clin Nutr 2002; 75(4): 720-727.
23. Mayer E. Heliotherapy of tuberculosis. Ann Int Med 1938; 11(10): 1856-1860.
24. Roelandts R. A new light on Niels Finsen, a century after his Nobel Prize. Photodermatol Photoimmunol Photomed 2005; 21(3): 115-117.
25. Askew FA, Bruce HM, Callow RK, Philpot JS, Webster TA, Crystalline, Vitamin D, Nature 1931; 128: 758.
26. Charpy J. Quelques traitments vitaminés ou par substances fonctionelles en dermatologie. Bull Méd 1950; 24: 505.
27. Martineau AR, Honecker FU, Wilkinson RJ, Griffiths CJ. Vitamin D in the treatment of pulmonary tuberculosis. J Steroid Biochem Mol Biol 2007; 103: 793-798.
28. Davies PD. A possible link between vitamin D deficiency and impaired host defence to Mycobacterium tuberculosis. Tubercle 1985; 66(4): 301-306.
29. Davies PD, Brown RC, Woodhead JS. Serum concentrations of vitamin D metabolites in untreated tuberculosis. Thorax 1985; 40(3): 187-190.
30. Davies PD, Church HA, Brown RC, Woodhead JS. Raised serum calcium in tuberculosis patients in Africa. Eur J Respir Dis 1987; 71(5): 341-344.
31. Davies PD, Church HA, Bovornkitti S, Charumilind A, Byrachandra S. Altered vitamin D homeostasis in tuberculosis. Int Med Thailand 1988; 4: 45-47.
32. Wilkinson RJ, Llewelyn M, Toossi Z, et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet 2000; 355(9204): 618-621.
33. Sasidharan PK, Rajeev E, Vijayakumari V. Tuberculosis and vitamin D deficiency. J Assoc Physicians India 2002; 50: 554-558.
34. Sita-Lumsden A, Lapthorn G, Swaminathan R, Milburn HJ. Reactivation of tuberculosis and vitamin D deficiency: the contribution of diet and exposure to sunlight. Thorax 2007; 62(11): 1003-1007.
35. Gibney KB, MacGregor L, Leder K, et al. Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa. Clin Infect Dis 2008; 46(3): 443-446.
36. Ho-Pham LT, Nguyen ND, Nguyen TT, et al. Association between vitamin D insufficiency and tuberculosis in a Vietnamese population. BMC Infect Dis 2010; 10: 306.
37. Grange JM, Davies PD, Brown RC, Woodhead JS, Kardjito T. A study of vitamin D levels in Indonesian patients with untreated pulmonary tuberculosis. Tubercle 1985; 66(3): 187-191.
38. Chan TY, Poon P, Pang J, et al. A study of calcium and vitamin D metabolism in Chinese patients with pulmonary tuberculosis. The Journal of tropical medicine and hygiene. 1994; 97(1): 26-30.
39. Martineau AR, Leandro AC, Anderson ST, et al. Association between Gc genotype and susceptibility to TB is dependent on vitamin D status. Eur Respir J 2010; 35(5): 1106-1112.
40. Nielsen NO, Skifte T, Andersson M, et al. Both high and low serum vitamin D concentrations are associated with tuberculosis: a case-control study in Greenland. Br J Nutr 2010: 104(10): 1487-1491.
41. Bellamy R, Ruwende C, Corrah T, et al. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J Infect Dis 1999; 179(3): 721-724.
42. Gao L, Tao Y, Zhang L, Jin Q. Vitamin D receptor genetic polymorphisms and tuberculosis: updated systematic review and meta-analysis. Int J Tuberc Lung Dis 2010; 14(1): 15-23.
43. Arnaud J, Constans J. Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP). Hum Genet 1993; 92(2): 183-188.
44. Lauridsen AL, Vestergaard P, Hermann AP, et al. Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxyvitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women. Calcif Tissue Int 2005; 77(1): 15-22.
45. Abbas S, Linseisen J, Slanger T, et al. The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin d status. Cancer Epidemiol Biomarkers Prev 2008; 17(6): 1339-1343.
46. Papiha SS, Agarwal SS, White I. Association between phosphoglucomutase (PGM1) and group-specific component (Gc) subtypes and tuberculosis. J Med Genet 1983; 20(3): 220-222.
47. Spitsyn VA, Titenko NV. [Subtypes of serum group specific component (Gc) in normal conditions and in pathology]. Genetika 1990; 26(4): 749-759.
48. Bahr GM, Eales LJ, Nye KE, et al. An association between Gc (vitamin D-binding protein) alleles and susceptibility to rheumatic fever. Immunology 1989; 67(1): 126-128.
49. Roth DE, Soto G, Arenas F, et al. Association between vitamin D receptor gene polymorphisms and response to treatment of pulmonary tuberculosis. J Infect Dis 2004; 190(5): 920-927.
50. Babb C, van der Merwe L, Beyers N, et al. Vitamin D receptor gene polymorphisms and sputum conversion time in pulmonary tuberculosis patients. Tuberculosis (Edinb) 2007; 87(4): 295-302.
51. Talat N, Perry S, Parsonnet J, Dawood G, Hussain R. Vitamin D deficiency and tuberculosis progression. Emerg Infect Dis 2010; 16(5): 853-855.
52. Kampmann B, Gaora PO, Snewin VA, Gares MP, Young DB, Levin M. Evaluation of human antimycobacterial immunity using recombinant reporter mycobacteria. J Infect Dis 2000; 182(3): 895-901.
53. Martineau AR, Wilkinson RJ, Wilkinson KA, et al. A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med 2007; 176(2): 208-213.
54. Gwinup G, Randazzo G, Elias A. The influence of vitamin D intake on serum calcium in tuberculosis. Acta Endocrinol (Copenh) 1981; 97(1): 114-117.
55. Martineau AR, Nanzer AM, Satkunam KR, et al. Influence of a single oral dose of vitamin D(2) on serum 25-hydroxyvitamin D concentrations in tuberculosis patients. Int J Tuberc Lung Dis 2009; 13(1): 119-125.
56. Narang NK, Gupta RC, Jain MK. Role of vitamin D in pulmonary tuberculosis. J Assoc Physicians India 1984; 32(2): 185-188.
57. Tjellesen L, Hummer L, Christiansen C, Rodbro P. Serum concentration of vitamin D metabolites during treatment with vitamin D2 and D3 in normal premenopausal women. Bone Miner 1986; 1(5): 407-413.
58. Stern PH, Taylor AB, Bell NH, Epstein S. Demonstration that circulating 1 alpha, 25-dihydroxyvitamin D is loosely regulated in normal children. J Clin Invest 1981; 68(5): 1374-1377.
59. Morcos MM, Gabr AA, Samuel S, et al. Vitamin D administration to tuberculous children and its value. Boll Chim Farm 1998; 137(5): 157-164.
60. Nursyam EW, Amin Z, Rumende CM. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones 2006; 38(1): 3-5.
61. Wejse C, Gomes VF, Rabna P, et al. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebocontrolled trial. Am J Respir Crit Care Med 2009; 179(9): 843-850.
62. Martineau AR, Timms PM, Bothamley GH, et al. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 2011; 377(9761): 242-250.
63. Vieth R. Vitamin D nutrient to treat TB begs the prevention question. Lancet 2011; 377(9761): 189-190.
64. Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis. A general review. Bibl Tuberc 1970; 26: 28-106.